Expensify (NASDAQ: EXFY) CEO awarded new long-term stock options
Filing Impact
Filing Sentiment
Form Type
4/A
Rhea-AI Filing Summary
Expensify, Inc. Chief Executive Officer David Michael Barrett reported receiving two stock option awards. On June 23, 2026, he was granted options covering 2,031,280 shares and 63,694 shares of Class A common stock, each with a $1.75 exercise price and expirations on June 23, 2036 and June 23, 2031, respectively. Both option grants vest in 16 equal quarterly installments deemed to have begun on April 12, 2025, and one of the reported options is fully vested and currently exercisable.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Barrett David Michael
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 63,694 | $0.00 | -- |
| Grant/Award | Stock Option | 2,031,280 | $0.00 | -- |
Holdings After Transaction:
Stock Option — 63,694 shares (Direct, null)
Footnotes (1)
- The stock option, aggregated with the stock option expiring 6/23/2036 reported herein, vests in 16 equal quarterly installments, deemed to have begun on April 12, 2025. This stock option is fully vested and currently exercisable. The stock option, aggregated with the stock option expiring 6/23/2031 reported herein, vests in 16 equal quarterly installments, deemed to have begun on April 12, 2025.
Key Figures
Large option grant size: 2,031,280 options
Second option grant size: 63,694 options
Exercise price: $1.75 per share
+3 more
6 metrics
Large option grant size
2,031,280 options
Grant dated June 23, 2026, expiring June 23, 2036
Second option grant size
63,694 options
Grant dated June 23, 2026, expiring June 23, 2031
Exercise price
$1.75 per share
Exercise price for both reported option grants
Options outstanding under 2036 grant
2,031,280 options
Total stock options following transaction for 2036-expiring grant
Options outstanding under 2031 grant
63,694 options
Total stock options following transaction for 2031-expiring grant
Vesting schedule
16 equal quarterly installments
Vesting deemed to begin on April 12, 2025
Key Terms
Stock Option, Class A Common Stock, vests in 16 equal quarterly installments, currently exercisable
4 terms
Stock Option financial
"The stock option, aggregated with the stock option expiring 6/23/2036 reported herein, vests in 16 equal quarterly installments"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Class A Common Stock financial
"underlying_security_title": "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
vests in 16 equal quarterly installments financial
"vests in 16 equal quarterly installments, deemed to have begun on April 12, 2025"
currently exercisable financial
"This stock option is fully vested and currently exercisable"
FAQ
What did Expensify (EXFY) CEO David Barrett report in this Form 4/A?
Expensify CEO David Barrett reported receiving two stock option grants. The awards cover Class A common stock and are structured as compensation, not open‑market purchases, with a fixed exercise price and long-dated expirations, aligning his incentives with future company performance.
What is the exercise price of David Barrett’s new Expensify (EXFY) stock options?
Both stock option awards carry a $1.75 per share exercise price. This means Barrett can buy Class A common shares at $1.75 once the options are vested and exercisable, regardless of the market price at that time, for the life of each option grant.
When do David Barrett’s new Expensify (EXFY) stock options expire?
The larger stock option grant expires on June 23, 2036, and the smaller grant expires on June 23, 2031. These long expiration dates provide a multi‑year window during which vested options can be exercised, subject to the plan’s and company’s standard conditions.
How do the Expensify (EXFY) CEO’s new option grants vest?
Both grants vest in 16 equal quarterly installments deemed to have begun on April 12, 2025. This creates a four‑year vesting period. A footnote states that one of the reported stock options is already fully vested and currently exercisable as of the reporting date.